For research use only
| Cat No. | ABC-TC3925 |
| Product Type | Mouse Primary Cells |
| Cell Type | Neuron |
| Species | CD-1 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Storage | Liquid Nitrogen |
CD-1 Mouse Striatum Neuron suspensions from AcceGen are high-quality embryonic neuronal cells, supporting neurodevelopmental and synaptic research.
CD-1 Mouse Striatum Neurons are primary cells isolated from the brain tissue of CD-1 mice. As primary neuronal cells, they are terminally differentiated and display a multipolar morphology with elaborate dendritic arbors and axonal projections essential for basal ganglia circuitry. Functionally, these striatum neurons mediate motor coordination, reward signaling, and cognitive functions, with involvement in neurodegenerative disorders like Parkinson’s and Huntington’s disease. They express NeuN and β-tubulin III. Karyotype analysis shows normal diploidy. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | CD-1 Mouse Striatum Neurons, CD1 Striatal Neurons, CD-1 Striatum Neuron Cells, Murine CD-1 Striatal Neurons |
| Species | CD-1 Mouse |
| Cat.No | ABC-TC3925 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Neuron |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
CD-1 Mouse Striatum Neurons serve as a relevant in vitro cellular model for investigating the pathogenesis of movement disorders and neurodegenerative diseases, including Huntington’s disease and Parkinson’s disease. Researchers can utilize these cells to investigate their susceptibility to dopaminergic neurodegeneration, synaptic plasticity, and response to neurotoxins or mutant proteins, enabling crucial insights into the molecular pathways underlying striatal dysfunction. This supports discovery research and molecular target identification related to movement-associated neurological disorders associated with aberrant striatal neuronal physiology in motor coordination and pathological dysregulation in disease pathogenesis.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).